The Involvement of PDE4 in the Protective Effects of Melatonin on Cigarette-Smoke-Induced Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a significant disease threatening human health. Currently, roflumilast, a phosphodiesterase (PDE)4 inhibitor, is recommended as a therapeutic agent for COPD. In this study, we investigated the therapeutic effects of melatonin against COPD, focusing on...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Je-Oh Lim, Woong-Il Kim, Se-Jin Lee, So-Won Pak, Young-Kwon Cho, Jong-Choon Kim, Joong-Sun Kim, In-Sik Shin
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/be80934177a8409d9fa158d331610697
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!